Female Hair Loss: Latest Treatments and Regrowth Options

Author: Dr. Hamid Hosseini, MD, MBioMed & PHD

 

(CEO & Founder of Hamita Biotech who discovered the unique formula of Dr. Hamid Hair Regrowth Products. A Clinician, Researcher & Immunologist who specialised in hair physiology & aesthetic medicine; Melbourne, Australia).

Introduction
Female Pattern Hair Loss (FPHL) is a common condition, affecting nearly 50% of women at some point in their lives. It is the most prevalent cause of hair loss in women, characterized by diffuse thinning that can lead to emotional and psychological challenges. While FPHL increases with age across all ethnicities, around 10% of women experience moderate to severe forms of this condition. Understanding FPHL, its triggers, risk factors, and treatments, is essential for managing its effects. (1–3)

 

What Is Female Pattern Hair Loss?
FPHL is a non-scarring type of hair loss that progresses gradually over time. It involves the transformation of thick, pigmented hair into fine, light-coloured hair through a process called hair follicle shrinking and miniaturization. The causes are not entirely clear but are believed to involve a combination of genetics, hormonal influences, and other factors. Hormones like testosterone and its more potent derivative, dihydrotestosterone (DHT), play a role in shrinking hair follicles, leading to hair loss.

Signs and Symptoms

FPHL typically starts with thinning hair along the central scalp, often creating a "Christmas tree" pattern when viewed from above. The hairline at the front usually remains intact, but the density of the hair on the crown decreases. Unlike male pattern baldness, temporal thinning (sides of the scalp) is less common in FPHL.

How FPHL Affects General Health
Hair loss is sometimes the first visible symptom of underlying health conditions. For instance, conditions like polycystic ovarian syndrome (PCOS), thyroid dysfunction, and even cardiovascular issues may manifest as alopecia. Research also indicates that patterned hair loss is linked to higher mortality from diabetes and heart disease. Screening for metabolic and cardiovascular risk factors is therefore vital for women presenting with significant hair loss.(4–6)

 

Risk Factors
Several factors increase the likelihood of developing FPHL:

• Age: The risk grows as women get older.
• Family History: Genetics play a significant role.
• Lifestyle: Smoking, prolonged sun exposure, and high stress levels are contributors.
• Underlying Health Issues: Elevated blood sugar and hormonal imbalances may also play a role.

Psychological effects are profound, with many women reporting negative body image, low self-esteem, and difficulty in personal and professional life due to hair loss.

Diagnosis of FPHL
Diagnosis is usually clinical, based on visible signs like thinning in a Christmas tree pattern and the absence of significant shedding. However, some symptoms, such as rapid hair loss, scalp irritation, or hair thinning in the temporal region, might suggest other conditions and should be further investigated. (7,8)

Treatment Options

1. Topical Treatments:
• Minoxidil: A first-line treatment, minoxidil stimulates hair follicles and promotes growth. Available in 2% and 5% concentrations, it has been proven to improve hair density in 60% of women.
2. Oral Treatments:
• Spironolactone: This medication reduces androgen activity, slowing hair loss and promoting regrowth.
• Low-dose oral minoxidil: Effective for long-term use in managing FPHL.
3. Lifestyle and Non-pharmacological Interventions:
• Avoiding harsh hair care practices.
• Using friction-free towels to minimize breakage.
• Opting for hairstyles that add volume, such as shorter cuts with layers.
4. Camouflage Techniques:
• Products like keratin fibers, scalp spray thickeners, and tinted lotions can cover thinning areas effectively.
5. Innovative Hair Care Products:
   One notable advancement in FPHL treatment includes Dr. Hamid Hair Regrowth Products, proudly Australian-made and grounded in natural ingredients. These products incorporate cutting-edge plant-driven stem cell technology, antioxidants, vitamins, and minerals to:
• Nourish hair follicles.
• Improve scalp health by removing toxins and restoring pH balance.
• Stimulate hair regrowth and stop further loss.

The unique formulation strengthens the entire hair shaft, ensuring a healthy and vibrant appearance. Regular use creates an optimal environment for hair to thrive, benefiting individuals of all ages, genders, and ethnicities.(9,10)

 

Counselling Points for Females Experiencing FPHL

• Realistic Expectations: Current treatments manage the condition but cannot cure it.
• Consistency: Most treatments require daily use for at least 3–6 months to show results and subsequently require a maintenance treatment plan. Discontinuation may reverse any progress.
• Practical Tips: Use gentle brushes and avoid heat damage.

 

Conclusion
FPHL is a complex condition with physical, psychological, and social impacts. While it is not entirely preventable, timely diagnosis and treatment can significantly improve the quality of life. Combining medical treatments, lifestyle changes, and advanced products like Dr. Hamid Hair Regrowth Products offers a holistic approach to managing FPHL effectively. By addressing both the physical and emotional aspects, women can regain confidence and lead fulfilling lives despite this challenging condition.

References:

1. Female pattern hair loss: Current treatment concepts.
2. Bertoli MJ, Sadoughifar R, Schwartz RA, Lotti TM, Janniger CK. Female pattern hair loss: A comprehensive review. Dermatol Ther. 2020 Nov;33(6):e14055.
3. Vujovic A, Del Marmol V. The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis. BioMed Research International. 2014;2014:1–8.
4. Su LH, Chen LS, Lin SC, Chen HH. Association of Androgenetic Alopecia With Mortality From Diabetes Mellitus and Heart Disease. JAMA Dermatol. 2013 May 1;149(5):601.
5. Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey. Journal of the American Academy of Dermatology. 2013 Aug;69(2):e69–77.
6. Arias-Santiago S, Gutiérrez-Salmerón MT, Buendía-Eisman A, Girón-Prieto MS, Naranjo-Sintes R. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia: Hypertension and aldosterone levels in women with early-onset AGA. British Journal of Dermatology. 2010 Apr;162(4):786–9.
7. Mubki T, Rudnicka L, Olszewska M, Shapiro J. Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination. J Am Acad Dermatol. 2014 Sep;71(3):415.e1-415.e15.
8. Ahanogbe I, Gavino ACP. Evaluation and Management of the Hair Loss Patient in the Primary Care Setting. Primary Care: Clinics in Office Practice. 2015 Dec;42(4):569–89.
9. Brough KR, Torgerson RR. Hormonal therapy in female pattern hair loss. International Journal of Women’s Dermatology. 2017 Mar;3(1):53–7.
10. Emer J, Lauren Levy LL. Female pattern alopecia: current perspectives. IJWH. 2013 Aug;541.